Tzu-chin Wu

Title: Tzu-chin Wu: Innovator in Neurotensin Receptor Research

Introduction

Tzu-chin Wu is a prominent inventor based in Miaoli, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work focuses on the neurotensin receptor 1 (NTSR1), which plays a crucial role in various physiological processes.

Latest Patents

Tzu-chin Wu holds a patent for "Humanized anti-human neurotensin receptor 1 antibodies and their uses." This patent describes a humanized anti-neurotensin receptor 1 (NTSR1) antibody or an antigen-binding fragment thereof. It also outlines methods for treating, prophylactic treating, and preventing diseases and disorders related to NTSR1 activity and signaling. Additionally, the patent includes a method or kit for detecting NTSR1 in a sample.

Career Highlights

Throughout his career, Tzu-chin Wu has worked with notable organizations such as the Development Center for Biotechnology and the National Health Research Institutes. His expertise in biotechnology has led to advancements in understanding and targeting NTSR1.

Collaborations

Tzu-chin Wu has collaborated with esteemed colleagues, including Ren-Huang Wu and Chao-Yang Huang. These partnerships have fostered innovation and contributed to the success of his research endeavors.

Conclusion

Tzu-chin Wu's work in developing humanized antibodies targeting NTSR1 showcases his commitment to advancing medical science. His contributions have the potential to lead to new treatments for various diseases, highlighting the importance of innovation in biotechnology.